← All patents

US20170296655A1

Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

University of Texas System

Abstract

Cyclic-GMP-AMP (cGAMP), including 2′,3′-cGAMP, are used in pharmaceutical formulations (including vaccine adjuvants), drug screens, therapies and diagnostics.

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Zhijian Chen
Priority date
December 19, 2012
Filing date
January 29, 2017
Publication date
October 19, 2017
Language
en
Metadata fetched
August 29, 2026 00:24